Ellyn Shocron

Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin

Chi‐Hui Tang, Christi Parham, Ellyn Shocron et al. · Cancer Chemotherapy and Pharmacology · 2010 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS).

Kamalesh K. Sankhala, Jean‐Yves Blay, Kristen N. Ganjoo et al. · Journal of Clinical Oncology · 2017 · 42 citations

Life Sciences, Immunology, Oncology +17

Regulation of Sphingosine-1-phosphate Lyase Gene Expression by Members of the GATA Family of Transcription Factors

Babak Oskouian, Jane Mendel, Ellyn Shocron et al. · Journal of Biological Chemistry · 2005 · 37 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +13

Discovery of 5-substituted 2-amino-4-chloro-8-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-7,8-dihydropteridin-6(5H)-ones as potent and selective Hsp90 inhibitors

Xiaoyuan Li, Ellyn Shocron, Aimin Song et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11